Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 23-29 , January 2009

Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study

  • Yazid Belkacémi

      Affiliations

    • Department of Radiation Oncology, Oscar Lambret Anti-Cancer Center, Cedex, France
    • Breast Cancer Unit, Oscar Lambret Center, Cedex, France
    • Lille II University, Lille, France
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Henri Mondor Hospital, 51 av Marchal de Lattre de Tassigny, 94000 Créteil, France.
    • ,
  • Marie-Pierre Chauvet

      Affiliations

    • Breast Cancer Unit, Oscar Lambret Center, Cedex, France
    • ,
  • Sylvia Giard

      Affiliations

    • Breast Cancer Unit, Oscar Lambret Center, Cedex, France
    • ,
  • Sylviane Villette

      Affiliations

    • Department of Radiation Oncology, Oscar Lambret Anti-Cancer Center, Cedex, France
    • ,
  • Thomas Lacornerie

      Affiliations

    • Department of Radiation Oncology, Oscar Lambret Anti-Cancer Center, Cedex, France
    • ,
  • François Bonodeau

      Affiliations

    • Department of Radiology, Oscar Lambret Center, Cedex, France
    • ,
  • Marie-Christine Baranzelli

      Affiliations

    • Department of Pathology, Oscar Lambret Center, Lille, France
    • ,
  • Jacques Bonneterre

      Affiliations

    • Breast Cancer Unit, Oscar Lambret Center, Cedex, France
    • Lille II University, Lille, France
    • ,
  • Eric Lartigau

      Affiliations

    • Department of Radiation Oncology, Oscar Lambret Anti-Cancer Center, Cedex, France
    • Lille II University, Lille, France

Received 28 August 2007 ,Revised 23 May 2008 ,Accepted 18 June 2008.

References 

  1. Hughes KS, Schnaper LA, Berry D, et al. Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–977
  2. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963–970
  3. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88:716–726
  4. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299–304
  5. Fentiman I, Poole C, Tong D, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32:417–420
  6. Cionini L, Pacini P, Marzano S, et al. Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon Chir. 1993;89:128;[Abstract]
  7. Krishnan L, Jewell WR, Tawfik OW, Krishnan EC. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  8. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001
  9. Clarke DH, Vicini F, Jacobs H, et al. High dose rate brachytherapy for breast cancer. In:  Armonk NS editors. High dose rate brachytherapy: a textbook. New York: Futura Publishing; 1994;
  10. Polgar C, Major T, Fodor J, et al. High-dose brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving: seven year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  11. Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol. 1997;65:263–267
  12. Ott OJ, Pötter R, Hammer J, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol. 2004;180:642–649
  13. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the mammosite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
  14. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: analysis of the variables associated with late toxicity and long-term cosmetic outcome after high-dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–495
  15. Kuske RR, Winter K, Arthur DW, et al. Phase II trial brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2006;65:45–51
  16. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for treatment of early-stage breast carcinoma. Cancer. 2006;106:991–999
  17. Formenti SC, Rosenstein B, Skinner KA, Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology. 2002;222:171–178
  18. Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57:1247–1253
  19. Baglan KL, Sharpe MB, Jaffray D, et al. Partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302–311
  20. Vicini F, Winter K, Straube W, et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of faisibility and reproducibility of radiation therapy oncology group study (RTOG) 0139. Int J Radiat Oncol Biol Phys. 2005;63:1531–1537
  21. Taghian AG, Kozak KR, Adams J, et al. Accelerated partial breast irradiation (APBI) using protons for patients with early-stage breast cancer: a comparison to 3D conformal photon/electrons based treatment. Proc Int J Radiat Oncol Biol. 2005;63:15;[Abstract]
  22. Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37:2178–2183
  23. Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol. 2001;12:1075–1080
  24. Vaidya JS, Baum M, Tobias JS, Morgan S, D’Souza D. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. EJSO. 2002;28:447–454
  25. Fentiman IS, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991;27:447–450
  26. Poti Z, Nemeskeri C, Fekeshazy A, et al. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys. 2004;58:1022–1033
  27. Trotti A, Colevas AD, Setser A, et al. CTCAEv3.0: development of a comprehensive grading for the adverse effects of cancer treatment. Sem Radiat Oncol. 2003;13:176–181
  28. Olivotto IA, Rose MA, Osteen RT, et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys. 1989;17:747–753
  29. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the functional assessement of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;14:974–986
  30. Gittleman M, Vigneri , Carlson DJ, et al. Clinical evaluation of the MammoSite breast brachytherapy: an analysis of technical reproducibility, acute toxicity and patients demographics. Int J Radiat Oncol Biol Phys. 2003;57:S365–S366
  31. Zannis JJ, Walker LC, Barclay-Wite B, Quiet CA. Post-operative ultra-sound-guided percutaneous placement of a new breast balloon catheter. Am J Surg. 2003;186:383–385
  32. Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high-dose intracavitary brachytherapy with mammosite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11:739–746
  33. Dowlatshahi K, Snider HC, Gittleman MA, et al. Early experience with balloon brachytherapy for breast cancer. Arch Surg. 2004;139:603–608
  34. Zannis V, Beitsch P, Vicini F, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg. 2005;190:530–538
  35. Shah NM, Wazer DE. The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation. Sem Radiat Oncol. 2005;15:100–107
  36. Shah NM, Tenenholz T, DiPetrillo T, et al. Initial cosmesis and toxicity with MammoSite brachytherapy for partial-breast irradiation in breast-conserving therapy for women with early-stage breast cancer. Brachytherapy. 2003;2:60–62
  37. Niehoff P, Polgar C, Ostertag H, et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316–320
  38. Tsai PI, Ryan M, Meek K, et al. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up. Am Surg. 2006;72:929–934
  39. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005;242:1–6
  40. Pawlick TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer. 2004;100:490–498
  41. Harper J, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE. Acute complications of MammoSite brachytherapy: a single institution initial clinical experience. Int J Radiat Oncol Biol Phys. 2005;61:169–174
  42. Vicini FA, Beitsch P, Quiet C, et al. First analysis of patient demographics and technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer. 2005;104:1138–1148
  43. Stolier AJ, Fuhrman GM, Scroggins TG, Boyer CI. Post lumpectomy insertion of the MammoSite brachytherapy device using the scare entry technique: initial experience and technical considerations. Breast J. 2005;11:199–203
  44. Dickler A, Kirk MC, Choo J, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J. 2005;11:303–305
  45. Agrawal A, Beriwal S, Heron D, et al. Accelerated partial breast irradiation: single institutional experience of 100 patients using MammoSite brachytherapy. Proc Int J Radiat Oncol Biol. 2005;63:11;[Abstract]
  46. Evans SB, Kaufman SA, Price LL, Cardarelli G, Dipetrillo TA, Wazer DE. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors. Int J Radiat Biol Phys. 2006;65:333–339
  47. Keisch M, Vicini F, Scroggins T, et al. Thirty-nine month results with the MammoSite brachytherapy applicator: details regarding cosmesis, toxicity and local control in partial breast irradiation. Proc Int J Radiat Oncol Biol. 2005;63:10;[Abstract]
  48. Turreson I. Individual variation and dose dependency in the progression rate of skin teleangiectasia. Int J Radiat Oncol Biol Phys. 1990;19:1569–1574
  49. Pandey M, Thomas BC, SreeRekha P, et al. Quality of life determinants in women with breast cancer undergoing curative intent. World J Surg Oncol. 2005;3:63–70
  50. Avis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol. 2005;23:3322–3330
  51. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16:501–514
  52. Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA. The process of recovery from breast cancer for young and older patients: changes during the first year. Cancer. 1990;65:1242–1254
  53. Levy SM, Haynes LT, Herberman RB, Lee J, McFeeley S, Kirkwood J. Mastectomy versus breast conservation surgery: mental health effects on long-term follow-up. Health Psychol. 1992;11:349–354
  54. Fallowfield LJ, Bliss JM, Porter LS, et al. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in post menopausal women with primary breast cancer. J Clin Oncol. 2006;24:910–917
  55. Pandey M, Thomas BC, Ramdas K, Ratheesan K. Early effect of surgery on quality of life in women with operable breast cancer. Jpn J Clin Oncol. 2006;36:468–472
  56. Belkacemi Y, Vicini F. High-dose brachytherapy using MammoSite applicator: “our doubts are traitors, and makes us lose the good we oft might win, by fearing to attempt!. Radiother Oncol. 2006;82:354–355

PII: S0167-8140(08)00329-0

doi: 10.1016/j.radonc.2008.06.004

Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 23-29 , January 2009

Article Tools

* Image Usage & Resolution